David Kaye’s practice focuses on venture capital investors, emerging companies and investment banking firms. He advises venture capital firms in connection with their investments in technology and life science startups and has experience working with emerging companies on a variety of complex corporate matters from inception to exit. His practice includes equity and debt financings, mergers & acquisitions, public offerings with both domestic and foreign issuers and general corporate law.

Download full bio 


  • COMPASS Pathways – $147 Million IPO 

  • NewsCred Asset Sale to Industry Dive and Falfurrias Capital Partners 

  • Schrodinger - $202 Million IPO 


  • UCLA School of Law
    JD, 2018

  • The George Washington University
    BA, Economics and Political Science
    magna cum laude, 2014

  • The London School of Economics and Political Science
    General Course Program, 2013

Admissions & Credentials

New York